AQP9 was involved in LPS-induced blood-brain barrier permeability and brain water content (Wang et al., 2009), and identified as a potential marker of chronic inflammation in patients with several different autoimmune diseases (Mesko et al., 2010). The gene discussed is AQP9; the disease is autoimmune disease.